Abstract
Vitreous hemorrhage secondary to proliferative diabetic retinopathy is one of the important causes of severe vision loss in diabetic patients. Although laser photocoagulation therapy is still the gold standard treatment for proliferative diabetic retinopathy, anti-VEGF injections can also be used as adjunctive therapy in preparation for surgery. For vitreous hemorrhages and fibrous tissue proliferation that do not resolve spontaneously, pars plana vitrectomy and endolaser treatment are required. With the developing surgical technique and fast recovery time, it is possible to recommend surgical intervention without waiting for a long time.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
